Finch Therapeutics' market value is the price at which a share of Finch Therapeutics trades on a public exchange. It measures the collective expectations of Finch Therapeutics Group investors about its performance. Finch Therapeutics is trading at 12.76 as of the 18th of February 2026. This is a 4.06 percent decrease since the beginning of the trading day. The stock's open price was 13.3. With this module, you can estimate the performance of a buy and hold strategy of Finch Therapeutics Group and determine expected loss or profit from investing in Finch Therapeutics over a given investment horizon. Check out Finch Therapeutics Correlation, Finch Therapeutics Volatility and Finch Therapeutics Performance module to complement your research on Finch Therapeutics.
Please note, there is a significant difference between Finch Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Finch Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Finch Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Finch Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Finch Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Finch Therapeutics.
0.00
11/20/2025
No Change 0.00
0.0
In 3 months and 1 day
02/18/2026
0.00
If you would invest 0.00 in Finch Therapeutics on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Finch Therapeutics Group or generate 0.0% return on investment in Finch Therapeutics over 90 days. Finch Therapeutics is related to or competes with Bonus BioGroup, Celyad Oncology, Starpharma Holdings, Charlottes Web, and Positron Corp. Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally admin... More
Finch Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Finch Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Finch Therapeutics Group upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Finch Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Finch Therapeutics' standard deviation. In reality, there are many statistical measures that can use Finch Therapeutics historical prices to predict the future Finch Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Finch Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Finch Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0648, which denotes the company had a -0.0648 % return per unit of risk over the last 3 months. Finch Therapeutics Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Finch Therapeutics' Standard Deviation of 1.79, variance of 3.19, and Mean Deviation of 1.2 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0414, which means not very significant fluctuations relative to the market. As returns on the market increase, Finch Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Finch Therapeutics is expected to be smaller as well. At this point, Finch Therapeutics has a negative expected return of -0.12%. Please make sure to confirm Finch Therapeutics' maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Finch Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation
0.31
Below average predictability
Finch Therapeutics Group has below average predictability. Overlapping area represents the amount of predictability between Finch Therapeutics time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Finch Therapeutics price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Finch Therapeutics price fluctuation can be explain by its past prices.
Other Information on Investing in Finch Pink Sheet
Finch Therapeutics financial ratios help investors to determine whether Finch Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Finch with respect to the benefits of owning Finch Therapeutics security.